Invest now
Divi's Laboratories Balance Sheet Annual
BSE: 532488 | NSE: DIVISLAB | ISIN: INE361B01024 | Sector: Biotechnology & Drugs8,518.50 +18.50 (0.22%)Updated : 14 Aug 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 20,033.00 | 16,932.00 | 15,470.00 | 14,438.77 |
| Accumulated Depreciation Total | -2,855.00 | -2,398.00 | -1,996.00 | -1,620.84 |
| Cash Equivalents | 81.00 | 394.00 | 340.00 | 140.77 |
| Other Liabilities Total | 755.00 | 0.00 | 37.00 | 30.62 |
| Accrued Expenses | 314.00 | 275.00 | 223.00 | 238.00 |
| Common Stock Total | 53.00 | 53.00 | 53.00 | 53.09 |
| Other Equity Total | 46.00 | 31.00 | 26.00 | 25.12 |
| Other Current Assets Total | 3,407.00 | 3,316.00 | 3,624.00 | 4,050.31 |
| Prepaid Expenses | 26.00 | 37.00 | 36.00 | 27.20 |
| Total Assets | 20,033.00 | 16,932.00 | 15,470.00 | 14,438.77 |
| Current Portof LT Debt/ Capital Leases | 2.00 | 0.00 | 1.00 | 0.49 |
| Additional Paid- In Capital | 80.00 | 80.00 | 80.00 | 79.88 |
| Cash | 47.00 | 21.00 | 23.00 | 28.93 |
| Total Equity | 16,761.00 | 14,969.00 | 13,571.00 | 12,767.09 |
| Long Term Investments | 69.00 | 65.00 | 82.00 | 77.05 |
| Retained Earnings( Accumulated Deficit) | 16,582.00 | 14,805.00 | 13,412.00 | 12,609.00 |
| Total Common Shares Outstanding | 26.55 | 26.55 | 26.55 | 26.55 |
| Property/ Plant/ Equipment Total- Gross | 11,490.00 | 8,858.00 | 7,509.00 | 6,550.04 |
| Tangible Book Valueper Share Common Eq | 631.15 | 563.72 | 511.06 | 480.73 |
| Total Liabilities | 3,272.00 | 1,963.00 | 1,899.00 | 1,671.68 |
| Total Debt | 7.00 | 4.00 | 3.00 | 3.26 |
| Cashand Short Term Investments | 128.00 | 415.00 | 363.00 | 169.70 |
| Total Receivables Net | 3,466.00 | 2,990.00 | 2,388.00 | 2,030.23 |
| Notes Payable/ Short Term Debt | 0.00 | 2.00 | 0.00 | 0.00 |
| Deferred Income Tax | 469.00 | 509.00 | 582.00 | 537.21 |
| Accounts Receivable- Trade Net | 3,109.00 | 2,731.00 | 2,156.00 | 1,792.53 |
| Property/ Plant/ Equipment Total- Net | 8,635.00 | 6,460.00 | 5,513.00 | 4,929.20 |
| Total Current Liabilities | 2,043.00 | 1,452.00 | 1,278.00 | 1,101.08 |
| Total Inventory | 4,069.00 | 3,323.00 | 3,264.00 | 3,034.30 |
| Accounts Payable | 1,211.00 | 910.00 | 824.00 | 762.51 |
| Other Currentliabilities Total | 516.00 | 265.00 | 230.00 | 100.08 |
| Total Long Term Debt | 5.00 | 2.00 | 2.00 | 2.77 |
| Intangibles Net | 6.00 | 4.00 | 4.00 | 5.28 |
| Other Long Term Assets Total | 85.00 | 75.00 | 68.00 | 95.67 |
| Note Receivable- Long Term | 142.00 | 247.00 | 128.00 | 19.83 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 11,096.00 | 10,081.00 | 9,675.00 | 9,311.74 |
| Capital Lease Obligations | 5.00 | 2.00 | 2.00 | 2.77 |
*All figures in crores except per share values
Divi's Laboratories Quick Links
Divi's Laboratories Dividend Divi's Laboratories Bonus Divi's Laboratories News Divi's Laboratories AGM Divi's Laboratories Rights Divi's Laboratories Splits Divi's Laboratories Board Meetings Divi's Laboratories Key Metrics Divi's Laboratories Shareholdings Divi's Laboratories Profit Loss Divi's Laboratories Cashflow Divi's Laboratories Q1 Results Divi's Laboratories Q2 Results Divi's Laboratories Q3 Results Divi's Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
5,098.20+155.20(3.14%)
1,102.85+20.85(1.93%)
2,024.95+23.05(1.15%)
1,072.00-24.05 (-2.19%)
310.50-4.95 (-1.57%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.